The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

UnitedHealth Group Inc

NYSE: UNH
Last

(U.S.) $102.49

Today's change+0.25 +0.24%
Updated December 19 4:03 PM EST. Delayed by at least 15 minutes.
 

UnitedHealth Group Inc

NYSE: UNH
Last

(U.S.) $102.49

Today's change+0.25 +0.24%
Updated December 19 4:03 PM EST. Delayed by at least 15 minutes.

UnitedHealth Group Inc Hits New 52-week High

UnitedHealth Group Inc closed up Friday by (U.S.)$0.25 or 0.24% to (U.S.)$102.49 and setting a new 52-week high. Over the last five days, shares have gained 3.78% and are currently 1.45% off of the 52-week high. Shares have outperformed the S&P 500 by 27.15% during the last year.

Key company metrics

  • Open(U.S.) $102.00
  • Previous close(U.S.) $102.24
  • High(U.S.) $104.00
  • Low(U.S.) $102.00
  • Bid / Ask-- / --
  • YTD % change+36.11%
  • Volume7,986,510
  • Average volume (10-day)4,420,936
  • Average volume (1-month)4,202,298
  • Average volume (3-month)4,132,593
  • 52-week range(U.S.) $69.57 to (U.S.) $104.00
  • Beta0.54
  • Trailing P/E18.30×
  • P/E 1 year forward18.16×
  • Forward PEG1.93×
  • Indicated annual dividend(U.S.) $1.50
  • Dividend yield1.46%
  • Trailing EPS(U.S.) $5.60
Updated December 19 4:03 PM EST. Delayed by at least 15 minutes.
S&P TSX0.85%Sector:HealthcareIndustry:Managed Health Care
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue32,75932,57431,70831,117
Total other revenue--------
Total revenue32,75932,57431,70831,117
Gross profit--------
Total cost of revenue--------
Total operating expense29,85630,02229,65428,665
Selling / general / administrative--------
Research & development--------
Depreciation / amortization373364360350
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total29,48329,65829,29428,315
Operating income2,9032,5522,0542,452
Interest income (expense), net non-operating-152-155-160-176
Gain (loss) on sale of assets--------
Other--------
Income before tax2,7512,3971,8942,276
Income after tax1,6021,4081,0991,427
Income tax, total1,149989795849
Net income1,6021,4081,0991,427
Total adjustments to net income--------
Net income before extra. items1,6021,4081,0991,427
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,6021,4081,0991,427
Inc. avail. to common incl. extra. items1,6021,4081,0991,427
Diluted net income1,6021,4081,0991,427
Dilution adjustment--------
Diluted weighted average shares982991983997
Diluted EPS excluding extraordinary itemsvalue per share1.631.421.121.43
Dividends per sharevalue per share0.380.380.280.28
Diluted normalized EPSvalue per share1.631.421.121.43